Peripheral Artery Occlusive Disease (PAOD) in Women Hospitalized for Type 1 Myocardial Infarction in Intensive Cardiology Care

Study of the Prevalence of Peripheral Artery Occlusive Disease (PAOD) in Women Hospitalized for Type 1 Myocardial Infarction in Intensive Cardiology Care

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05149456

Acronym

AOMI

Enrollment

Registered

2021-12-08

Start date

2021-08-15

Completion date

2022-08-31

Last updated

2021-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PAOD - Peripheral Arterial Occlusive Disease

Keywords

Peripheral Arterial Occlusive Disease, PAOD, Cardiovascular risk factors, Myocardial infarction

Brief summary

The cardiovascular risk of women has been the subject of particular interest in recent years, in the world, in particular under the impetus of Cardiology companies, with more and more work focusing on the specificities of these diseases in women as well as differences in terms of management and prognosis with a literature mainly based on American data and which focuses particularly on ischemic heart disease. The expected results are to have a prevalence of PAOD in an Alsatian cohort, most of the data we currently have from American data, with analysis of the impact of specific and non-specific risk factors in this cohort and their weight in PAOD.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult woman (≥18 years old) * Patient hospitalized in an Intensive Cardiology Unit (ICU) at the HUS for a type 1 myocardial infarction confirmed according to the criteria of the fourth universal definition of the ESC between 01/01/2021 to 30/06/2021 inclusive * Patient who did not express her opposition to the reuse of her data for scientific research purposes.

Exclusion criteria

* Patient who expressed her opposition to participating in the study * Impossibility of providing the subject with enlightened information (difficulties in understanding the subject, MMS \<20/30…) * Non-type 1 or unconfirmed myocardial infarction * Unstable or refractory shock state at the time of the echodoppler examination * Complication of the coronary angiography approach, in the case of femoral approach only, requiring surgical management. * Patient under curatorship, guardianship or judicial safeguard.

Design outcomes

Primary

Measure	Time frame
Study of the prevalence of peripheral artery occlusive disease (PAOD)	Files analysed retrospectively from January 01, 2021 to Jun 30, 2021 will be examined]

Countries

France

Contacts

Primary ContactDominique STEPHAN, MD, PhD

dominique.stephan@chru-strasbourg.fr33 3 69 55 09 52

Backup ContactSaïd CHAYER, PhD, HDR

said.chayer@chru-strasbourg.fr

Outcome results